A Comparative Study Between the Usage of Flexible and Navigable Suction Ureteral Access Sheath Versus Traditional Access Sheath in Retrograde Intrarenal Surgeries
Launched by YOSSEIF ELHOUSSEINY AMMAR AHMED · Jul 11, 2025
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different tools used during a type of kidney stone surgery called Retrograde Intrarenal Surgery (RIRS). One tool is a newer, flexible suction device designed to help remove kidney stones more easily, while the other is the traditional tool commonly used. The goal is to see which tool works better or offers advantages during the procedure.
The study is open to people aged 14 and older who have kidney stones up to 2 centimeters in size, confirmed by a CT scan, and who do not have certain medical conditions that cause stones or unusual kidney anatomy. Participants should not have infected urine or a history of major kidney surgeries on the affected side. If you join, you’ll be randomly assigned to have surgery with either the new flexible suction tool or the traditional one, and the doctors will compare the results to learn which method is safer or more effective. This study is still recruiting patients, and anyone interested should meet the eligibility criteria and be able to follow the study instructions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥14 years old in patients not known to have stone forming medical conditions.
- • Renal stones diameter of ≤2 cm confirmed by CT with all types of configurations (branching \& non-branching).
- • Non - recurrent cases with no history of previous open renal surgeries or PCNL with normal renal anatomy.
- • Patients with non - infected urine analysis.
- Exclusion Criteria:
- • Patients with abnormal urinary tract anatomy (such as horseshoe kidney or ileal conduit).
- • Patients with medical conditions promoting stone formation (hyperparathyroidism - gout).
- • Patients with history of stones on the same side with previous open surgical intervention or PCNL .
- • Patients with e-GFR \< 60 ml / min.
- • Patients with uncontrolled urinary tract infection.
- • Patients with health or other factors that are absolute contraindications to RIRS.
- • Patients who are unable to understand or complete trial documentation.
About Yosseif Elhousseiny Ammar Ahmed
Yosseif Elhousseiny Ammar Ahmed is a clinical trial sponsor dedicated to advancing medical research through the support and oversight of innovative clinical studies. Committed to upholding the highest standards of scientific rigor and patient safety, the sponsor actively collaborates with research institutions and healthcare professionals to facilitate the development of effective and safe therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ahmed Yehia Abdelaziz Mohammed, Professor of urology
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported